Diatech Pharmacogenetics announced an expansion of its collaboration with Merck Serono Middle East Ltd., affiliates of ... accounting for approximately 10% of all cancer cases. Colon cancer is the ...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver Leave Benefit as an addition ...
She said the findings support the current standard of care using systemic therapy alone for most patients while leaving room for consideration of chemoradiation in selected cases, particularly ...
First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant metastatic colorectal cancer (mCRC), according to the BREAKWATER trial. The study ...
At the forthcoming Pharmaccess Leaders Forum Spring conference, Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono ... “In the case of the UK affiliate of ...
Antibodies in clinical development that target PD-L1 include MPDL3280A (Genentech, South San Francisco, CA, USA), MEDI4736 (MedImmune/AstraZeneca) and MSB0010718C (EMD Serono, Rockland ...
The Court of Appeal maintained the status quo while considering, and rejecting, an appeal brought by Merck Serono over its attempt to obtain a UK SPC for cladribine. The result of the Court of ...
Competing interests GG: Part-time consultant for the CDC for acute flaccid myelitis case review, honoraria as Media editor ... Bristol Myers Squibb, Genentech, EMD Serono, I-Mab Biopharma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results